YESTAR HEALTH (02393) announced that on October 21, 2025, the buyer, YESTAR High-Performance Materials (Hong Kong) Limited, an indirect wholly-owned subsidiary of the company, entered into the first agreement with the seller, Genius Commerce Limited, for the acquisition of production equipment. The equipment includes a pre-crosslinked mixing system, coating solution mixing system, coating solution delivery system, module evaluation system, and other accessories, with a total consideration of $1.85 million.
On February 6, 2026, the buyer entered into a second agreement with the seller for the acquisition of primary equipment. The primary equipment consists of production and testing machinery for high-performance materials, including a film coating production line system, evaluation system, product packaging system, plasma treatment system, and other accessories, along with related consumables and materials for production. The total consideration for this acquisition is $5.35 million. Together, these two transactions are referred to as "the Acquisitions."
As previously disclosed in the company's announcement dated December 15, 2025, the company has been exploring and proposing investments in the high-performance materials industry, as well as upgrading its research and development equipment. The objective is to establish itself as a high-performance materials engineering company and manufacturer. The high-performance materials sector operates within the manufacturing segment, focusing on the design, construction, and commercialization of substances that perform at least an order of magnitude better than traditional counterparts in key characteristics.
The group is actively seeking and purchasing coating production lines and research and development equipment for high-performance materials. The acquired production and primary equipment represent significant R&D assets and a comprehensive coating production line. This will enable the group to conduct research, testing, and evaluation, and ultimately produce and manufacture high-performance film materials.
The board of directors believes that the Acquisitions will facilitate the group's transition into the high-performance materials industry, establishing it as a self-reliant high-performance materials engineering company and manufacturer. This move directly aligns with the group's current business strategy. Furthermore, leveraging the experience accumulated over the past two years in the precision production of S2 film cameras, the board believes the Acquisitions will diversify the group's business segments through synergies in material research and development.